There are good reasons to invest in the long-term potential of these growth stocks.
The U.S. Supreme Court on Thursday blocked Purdue Pharma's bankruptcy settlement, which would have shielded the Sackler family from lawsuits related to their role in the opioid crisis. The decision reversed...
Author's Note: Sometimes a stock will come up continually on my screeners. MCK was featured 10/16/2023 when it was trading at $462.56. The stock has gained 30%+ since then. The Chart of the Day belongs...
The S&P 500 and Nasdaq Composite are up nearly 16% and 21% year-to-date, respectively, yet there are more 52-week lows (262) compared to 52-week highs (119). That says a lot about the concentration of...
/Mckesson%20Corporation%20logo%20on%20building-by%20JHVEPhoto%20via%20iStock.jpg)
McKesson has outperformed other healthcare stocks over the past three months, and analysts remain optimistic about the stock’s prospects.
After CONMED's 33% slump this year, does its sharp rally off the April lows suggest the worst is over for this growth stock?
MCK earnings call for the period ending March 31, 2024.
June S&P 500 E-Mini futures (ESM24) are up +0.09%, and June Nasdaq 100 E-Mini futures (NQM24) are down -0.02% this morning after three major U.S. benchmark indices ended the regular session higher as recent...
Here's an ETF that outperforms the S&P 500 over a longer time horizon.